Acquisition Partners IV Llc Graf serves as Executive at NKGen Biotech, Inc., where they oversee executive responsibilities. Since joining the company, Acquisition Partners IV Llc Graf has executed 2 insider transactions totaling $67, demonstrating a bullish approach to their equity position. Their most recent transaction on Nov 21, 2023 involved purchasing 13 shares valued at $38.
Acquisition Partners IV Llc Graf currently holds 23 shares of NKGen Biotech, Inc. (NKGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Acquisition Partners IV Llc Graf has been a net buyer of NKGN stock. They have purchased $67 and sold $0 worth of shares.
Acquisition Partners IV Llc Graf's most recent insider trade was on Nov 21, 2023, when they purchased 13 shares at $2.92 per share.
Get notified when new Form 4 filings are submitted
| $2.94 |
| Discretionary |